| Q35970298 | A humanized monoclonal antibody targeting Staphylococcus aureus |
| Q35110799 | Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization |
| Q38975521 | Bacteriophages and its applications: an overview |
| Q34208861 | Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. |
| Q39675245 | CRISPR-Cas Defense System and Potential Prophages in Cyanobacteria Associated with the Coral Black Band Disease |
| Q40393500 | Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae. |
| Q54334624 | Characterization of 4 T1-like lytic bacteriophages that lyse Shiga-toxin Escherichia coli O157:H7. |
| Q28394377 | Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections |
| Q62734230 | Computational Prediction of Host-Pathogen Interactions Through Omics Data Analysis and Machine Learning |
| Q59330188 | Computational prediction of inter-species relationships through omics data analysis and machine learning |
| Q92800186 | Editorial: Environmental Bacteriophages: From Biological Control Applications to Directed Bacterial Evolution |
| Q35635891 | Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice |
| Q33622945 | Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection |
| Q37283951 | Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens |
| Q35790800 | Immunotherapeutics for nosocomial infections |
| Q36059113 | In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections |
| Q44004483 | Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains |
| Q24563742 | Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs' |
| Q42203724 | Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol |
| Q82823387 | Occurrence of Vibrio parahaemolyticus and its specific phages from shrimp ponds in east coast of India |
| Q37389925 | Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. |
| Q34612392 | Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production |
| Q34181298 | Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice |
| Q38230407 | Phage therapy: eco-physiological pharmacology |
| Q33754549 | Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals |
| Q52666848 | Protein Expression Modifications in Phage-Resistant Mutants of Aeromonas salmonicida after AS-A Phage Treatment. |
| Q39383695 | Rethinking the composition of a rational antibiotic arsenal for the 21st century |
| Q55128431 | Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. |
| Q39044881 | The roles of bacteriophages in membrane-based water and wastewater treatment processes: A review. |
| Q58566802 | Therapeutic Potential of a New Jumbo Phage That Infects , a Widespread Coral Pathogen |
| Q64059313 | Towards Inhaled Phage Therapy in Western Europe |